July 25, 2016
An Illinois federal judge on Monday granted class certification to a proposed group of glaucoma patients who accused Allergan Inc. and other drugmakers of violating consumer protection laws by selling eye drops in bottles that dispensed higher-than-normal doses, finding that their common issue outweighed individual questions.